coronavirus has brought the entire world to a standstill. So far, there are 1,015,877 cases and 53,218 deaths of COVID-19. A quarter of the total cases were recorded in the United States. In india, the total number of cases is inching towards the 2500 mark. A majority of the cases are related to a Religious event in Delhi. Meanwhile, efforts are on to prepare medicine and vaccine for this contagious disease.
hyderabad based Vaccine maker Bharat Biotech announced on friday that it is developing a unique intranasal vaccine for coronavirus treatment. An international collaboration of virologists at the university of Wisconsin-Madison and the vaccine companies FluGen along with Bharat Biotech has begun the development and testing of a unique vaccine against COVID-19 called CoroFlu.
Animal trials are expected to take three to six months. Bharat Biotech in hyderabad will then begin production scale-up for safety and efficacy testing in humans. CoroFlu could be in human clinical trials by the fall of 2020. It will be a proud moment for everyone if an indian company manages to produce this vaccine first among all the companies across the globe.
